Current understanding of the etiology of cyclic vomiting syndrome and therapeutic strategies in its management

References

• Li BU, Misiewicz L. Cyclic vomiting syndrome: a brain-gut disorder. Gastroenterol Clin North Am. 2003;32(3):997–1019.
   Google Scholar
• Heberden W. Commentaries on the history and cure of diseases. London: T. Payne; 1802.
   Google Scholar
• Gee S. On fitful or recurrent vomiting. St Bart Hosp Rep. 1882;18:1–6.
   Google Scholar
• Tack J, Nicholas J, Talley CM, et al. Fuctional Gastroduodenal. Gastroenterology. 2006;130(5):1466–1479.
   Google Scholar
• Drossman DA, Hasler WL. Rome IV—functional GI disorders: disorders of gut-brain interaction. Gastroenterology. 2016;150(6):1257–1261.
   Google Scholar
• • Li BU, Lefevre F, Chelimsky GG, et al., North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition consensus statement on the diagnosis and management of cyclic vomiting syndrome. J Pediatr Gastroenterol Nutr. 2008;47(3):379–393.
   Google Scholar
• •• Aziz I, Palsson OS, Whitehead WE, et al., Epidemiology, clinical characteristics, and associations for rome iv functional nausea and vomiting disorders in adults. Clin Gastroenterol Hepatol. 2019;17(5):878–886.
   Google Scholar
• Abu-Arafeh I, Russell G. Cyclical vomiting syndrome in children: a population-based study. J Pediatr Gastroenterol Nutr. 1995;21(4):454–458.
   Google Scholar
• Ertekin V, Selimoglu MA, Altnkaynak S. Prevalence of cyclic vomiting syndrome in a sample of Turkish school children in an urban area. J Clin Gastroenterol. 2006;40(10):896–898.
   Google Scholar
• Abell TL, Adams KA, Boles R, et al. Cyclic vomiting syndrome in adults. Neurogastroenterol Motility. 2008;20(4):269–284.
   Google Scholar
• Haghighat M, Rafie SM, Dehghani SM, et al. Cyclic vomiting syndrome in children: experience with 181 cases from southern Iran. World J Gastroenterol. 2007;13(12):1833.
   Google Scholar
• • Sagar RC, Sood R, Gracie DJ, et al. Cyclic vomiting syndrome is a prevalent and under-recognized condition in the gastroenterology outpatient clinic. Neurogastroenterol Motil. 2018;30(1):30.
   Google Scholar
• • Fleisher DR, Gornowicz B, Adams K, et al., Cyclic Vomiting Syndrome in 41 adults: the illness, the patients, and problems of management. BMC Med. 2005;3(1):20.
   Google Scholar
• Chelimsky TC, Chelimsky GG. Autonomic abnormalities in cyclic vomiting syndrome. J Pediatr Gastroenterol Nutr. 2007;44(3):326–330.
   Google Scholar
• Chelimsky G, Madan S, Alshekhlee A, et al. A comparison of dysautonomias comorbid with cyclic vomiting syndrome and with migraine. Gastroenterol Res Pract. 2009;2009:701019.
   Google Scholar
• Song X, Chen YJ, Perry A, et al. S1338 productivity loss and indirect burden of cyclic vomiting syndrome (CVS) in the United States. Am J Gastroenterol ACG. 2020;115(1):S674–S675.
   Google Scholar
• • Venkatesan T, Tarbell S, Adams K, et al., A survey of emergency department use in patients with cyclic vomiting syndrome. BMC Emerg Med. 2010;10(1):4.
   Google Scholar
• Kumar N, Bashar Q, Reddy N, et al. Cyclic Vomiting Syndrome (CVS): is there a difference based on onset of symptoms–pediatric versus adult? BMC Gastroenterol. 2012;12(1):52.
   Google Scholar
• • Bhandari S, Venkatesan T. Clinical characteristics, comorbidities and hospital outcomes in hospitalizations with cyclic vomiting syndrome: a nationwide analysis. Dig Dis Sci. 2017;62(8):2035–2044.
   Google Scholar
• Fleisher DR. Cyclic vomiting syndrome and migraine. J Pediatr. 1999;134(5):533–535.
   Google Scholar
• Stickler GB. Relationship between cyclic vomiting syndrome and migraine. Clin Pediatr (Phila). 2005;44(6):505–508.
   Google Scholar
• Yu ES, Priyadharsini SSY, Venkatesan TM. Cyclic vomiting syndrome, and other gastrointestinal disorders. Curr Treat Options Gastroenterol. 2018;16(4):511–527.
   Google Scholar
• Boles RG, Williams JC. Mitochondrial disease and cyclic vomiting syndrome. Dig Dis Sci. 1999;44(8 Suppl):103s–107s.
   Google Scholar
• Zaki EA, Freilinger T, Klopstock T, et al. Two common mitochondrial DNA polymorphisms are highly associated with migraine headache and cyclic vomiting syndrome. Cephalalgia. 2009;29(7):719–728.
   Google Scholar
• Lee J, Wong S, Li B, et al. NextGen nuclear DNA sequencing in cyclic vomiting syndrome reveals a significant association with the stress-induced calcium channel (RYR2). Neurogastroenterol Motility. 2015;27(7):990–996.
   Google Scholar
• Moavero R, Papetti L, Bernucci MC, et al. Cyclic vomiting syndrome and benign paroxysmal torticollis are associated with a high risk of developing primary headache: a longitudinal study. Cephalalgia. 2019;39(10):1236–1240.
   Google Scholar
• Tarbell S, Li BU. Psychiatric symptoms in children and adolescents with cyclic vomiting syndrome and their parents. Headache. 2008;48(2):259–266.
   Google Scholar
• Higashimoto T, Baldwin EE, Gold JI, et al. Reflex sympathetic dystrophy: complex regional pain syndrome type I in children with mitochondrial disease and maternal inheritance. Arch Dis Child. 2008;93(5):390–397.
   Google Scholar
• Venkatesan T, Zaki EA, Kumar N, et al. Quantitative pedigree analysis and mitochondrial DNA sequence variants in adults with cyclic vomiting syndrome. BMC Gastroenterol. 2014;14(1):181.
   Google Scholar
• Rozen TD, Oshinsky ML, Gebeline CA, et al. Open label trial of coenzyme Q10 as a migraine preventive. Cephalalgia. 2002;22(2):137–141.
   Google Scholar
• Markley HG. CoEnzyme Q10 and riboflavin: the mitochondrial connection. Headache. 2012;52 Suppl 2:81–87.
   Google Scholar
• • Ellingsen DM, Garcia RG, Lee J, et al., Cyclic Vomiting Syndrome is characterized by altered functional brain connectivity of the insular cortex: a cross-comparison with migraine and healthy adults. Neurogastroenterol Motil. 2017;29(6):e13004.
   Google Scholar
• • Venkatesan T, Prieto T, Barboi A, et al., Autonomic nerve function in adults with cyclic vomiting syndrome: a prospective study. Neurogastroenterol Motil. 2010;22(12):1303–7, e339.
   Google Scholar
• Rashed H, Abell T, Familoni B, et al. Autonomic function in cyclic vomiting syndrome and classic migraine. Dig Dis Sci. 1999;44(8 Suppl):74S–78S.
   Google Scholar
• To J, Issenman RM, Kamath MV. Evaluation of neurocardiac signals in pediatric patients with cyclic vomiting syndrome through power spectral analysis of heart rate variability. J Pediatr. 1999;135(3):363–366.
   Google Scholar
• Babygirija R, Sood M, Kannampalli P, et al. Percutaneous electrical nerve field stimulation modulates central pain pathways and attenuates post-inflammatory visceral and somatic hyperalgesia in rats. Neuroscience. 2017;356:11–21.
   Google Scholar
• Krasaelap A, Sood MR, Li B, et al. Efficacy of auricular neurostimulation in adolescents with irritable bowel syndrome in a randomized, double-blind trial. Clin Gastroenterol Hepatol. 2020;18(9):1987–1994. e2.
   Google Scholar
• • Kovacic K, Kolacz J, Lewis GF, et al., Impaired vagal efficiency predicts auricular neurostimulation response in adolescent functional abdominal pain disorders. Am J Gastroenterol. 2020;115(9):1534–1538.
   Google Scholar
• McEwen BS, Wingfield JC. The concept of allostasis in biology and biomedicine. Horm Behav. 2003;43(1):2–15.
   Google Scholar
• •• Hasler WL, Levinthal DJ, Tarbell SE, et al., Cyclic vomiting syndrome: pathophysiology, comorbidities, and future research directions. Neurogastroenterol Motil. 2019;31(Suppl 2):e13607.
   Google Scholar
• Juster R-P, McEwen BS, Lupien SJ. Allostatic load biomarkers of chronic stress and impact on health and cognition. Neurosci Biobehav Rev. 2010;35(1):2–16.
   Google Scholar
• Levinthal D, Bielefeldt K. Adult cyclical vomiting syndrome: a disorder of allostatic regulation? Exp Brain Res. 2014;232(8):2541–2547.
   Google Scholar
• Levinthal DJ. The cyclic vomiting syndrome threshold: a framework for understanding pathogenesis and predicting successful treatments. Clin Transl Gastroenterol. 2016;7(10):e198.
   Google Scholar
• Russo EB. Clinical endocannabinoid deficiency reconsidered: current research supports the theory in migraine, fibromyalgia, irritable bowel, and other treatment-resistant syndromes. Cannabis Cannabinoid Res. 2016;1(1):154–165.
   Google Scholar
• Sato T, Igarashi N, Minami S, et al. Recurrent attacks of vomiting, hypertension and psychotic depression: a syndrome of periodic catecholamine and prostaglandin discharge. Eur J Endocrinol. 1988;117(2):189–197.
   Google Scholar
• • Venkatesan T, Zadvornova Y, Raff H, et al., Endocannabinoid-related lipids are increased during an episode of cyclic vomiting syndrome. Neurogastroenterol Motil. 2016;28(9):1409–1418.
   Google Scholar
• • Wasilewski A, Lewandowska U, Mosinska P, et al., Cannabinoid receptor type 1 and mu-opioid receptor polymorphisms are associated with cyclic vomiting syndrome. Am J Gastroenterol. 2017;112(6):933–939.
   Google Scholar
• Baron EP. Comprehensive review of medicinal marijuana, cannabinoids, and therapeutic implications in medicine and headache: what a long strange trip it’s been … . Headache. J Headache Pain. 2015;55:885–916.
   Google Scholar
• •• Venkatesan T, Levinthal DJ, BUK L, et al., Role of chronic cannabis use: cyclic vomiting syndrome vs cannabinoid hyperemesis syndrome. Neurogastroenterol Motil. 2019;31(Suppl 2):e13606.
   Google Scholar
• Allen J, De Moore G, Heddle R, et al. Cannabinoid hyperemesis: cyclical hyperemesis in association with chronic cannabis abuse. Gut. 2004;53(11):1566–1570.
   Google Scholar
• Habboushe J, Rubin A, Liu H, et al. The prevalence of cannabinoid hyperemesis syndrome among regular marijuana smokers in an urban public hospital. Basic Clin Pharmacol Toxicol. 2018;122(6):660–662.
   Google Scholar
• Nicolson SE, Denysenko L, Mulcare JL, et al. Cannabinoid hyperemesis syndrome: a case series and review of previous reports. Psychosomatics. 2012;53(3):212–219.
   Google Scholar
• Spindle TR, Bonn-Miller MO, Vandrey R. Changing landscape of cannabis: novel products, formulations, and methods of administration. Curr Opin Psychol. 2019;30:98–102.
   Google Scholar
• Stanghellini V, Chan FK, Hasler WL, et al. Gastroduodenal Disorders. Gastroenterology. 2016;150(6):1380–1392.
   Google Scholar
• Li B, Balint JP. Cyclic vomiting syndrome: evolution in our understanding of a brain-gut disorder. Adv Pediatr. 2000;47:117–160.
   Google Scholar
• •• Venkatesan T, Levinthal DJ, Tarbell SE, et al., Guidelines on management of cyclic vomiting syndrome in adults by the American Neurogastroenterology and motility society and the cyclic vomiting syndrome association. Neurogastroenterol Motil. 2019;31(Suppl 2):e13604.
   Google Scholar
• Lucia-Casadonte CJ, Whaley KG, Chogle AS. Yield and costs of evaluating children with cyclic vomiting syndrome. J Pediatr Gastroenterol Nutr. 2018;67(1):13.
   Google Scholar
• Hsu J, Herrmann Z, Kashyap S, et al. Treatment of cannabinoid hyperemesis with olanzapine: a case series. J Psychiatr Pract. 2021;27(4):316–321.
   Google Scholar
• Kovacic K, Sood M, Venkatesan T. Cyclic Vomiting Syndrome in children and adults: what is new in 2018? Curr Gastroenterol Rep. 2018;20(10):46.
   Google Scholar
• Li BU. Managing cyclic vomiting syndrome in children: beyond the guidelines. Eur J Pediatr. 2018;177(10):1435–1442.
   Google Scholar
• • Slutsker B, Konichezky A, Gothelf D. Breaking the cycle: cognitive behavioral therapy and biofeedback training in a case of cyclic vomiting syndrome. Psychol Health Med. 2010;15(6):625–631.
   Google Scholar
• • Venkatesan T, Porcelli A, Matapurkar A, et al., An integrative healthcare model with heartfulness meditation and care coordination improves outcomes in cyclic vomiting syndrome. Neurogastroenterol Motil. 2021;33(11):e14132.
   Google Scholar
• Hejazi RA, Reddymasu SC, Namin F, et al. Efficacy of tricyclic antidepressant therapy in adults with cyclic vomiting syndrome: a two-year follow-up study. J Clin Gastroenterol. 2010;44(1):18–21.
   Google Scholar
• Boles RG. High degree of efficacy in the treatment of cyclic vomiting syndrome with combined co-enzyme Q10, L-carnitine and amitriptyline, a case series. BMC Neurol. 2011;11(1):102.
   Google Scholar
• Ho EY. Continuing medical education questions: january 2018: prophylactic therapy of cyclic vomiting syndrome in children: comparison of amitriptyline and cyproheptadine: a randomized clinical trial. Am J Gastroenterol. 2018;113(1):141.
   Google Scholar
• Namin F, Patel J, Lin Z, et al. Clinical, psychiatric and manometric profile of cyclic vomiting syndrome in adults and response to tricyclic therapy. Neurogastroenterol Motil. 2007;19(3):196–202.
   Google Scholar
• Sharaf RN, Venkatesan T, Shah R, et al. Management of cyclic vomiting syndrome in adults: evidence review. Neurogastroenterol Motil. 2019;31(Suppl 2):e13605.
   Google Scholar
• Sezer OB, Sezer T. A new approach to the prophylaxis of cyclic vomiting: topiramate. J Neurogastroenterol Motil. 2016;22(4):656–660.
   Google Scholar
• Sankar R, Ramsay E, McKay A, et al. A multicenter, outpatient, open-label study to evaluate the dosing, effectiveness, and safety of topiramate as monotherapy in the treatment of epilepsy in clinical practice. Epilepsy Behav. 2009;15(4):506–512.
   Google Scholar
• Lamb EJ, Stevens PE, Nashef L. Topiramate increases biochemical risk of nephrolithiasis. Ann Clin Biochem. 2004;41(2):166–169.
   Google Scholar
• Biton V. Clinical pharmacology and mechanism of action of zonisamide. Clin Neuropharmacol. 2007;30(4):230–240.
   Google Scholar
• Deshpande LS, DeLorenzo RJ. Mechanisms of levetiracetam in the control of status epilepticus and epilepsy. Front Neurol. 2014;5:11.
   Google Scholar
• Clouse RE, Sayuk GS, Lustman PJ, et al. Zonisamide or levetiracetam for adults with cyclic vomiting syndrome: a case series. Clin Gastroenterol Hepatol. 2007;5(1):44–48.
   Google Scholar
• Brodie M, Ben‐Menachem E, Chouette I, et al. Zonisamide: its pharmacology, efficacy and safety in clinical trials. Acta Neurol Scand. 2012;126:19–28.
   Google Scholar
• Van Laere K, De Hoon J, Bormans G, et al. Equivalent dynamic human brain NK1‐receptor occupancy following single‐dose iv fosaprepitant vs. oral aprepitant as assessed by PET imaging. Clin Pharmacol Ther. 2012;92(2):243–250.
   Google Scholar
• • Patel L, Lindley C. Aprepitant–a novel NK1-receptor antagonist. Expert Opin Pharmacother. 2003;4(12):2279–2296.
   Google Scholar
• Cristofori F, Thapar N, Saliakellis E, et al. Efficacy of the neurokinin‐1 receptor antagonist aprepitant in children with cyclical vomiting syndrome. Aliment Pharmacol Ther. 2014;40(3):309–317.
   Google Scholar
• Cameron C, Kelly S, Hsieh SC, et al. Triptans in the acute treatment of migraine: a systematic review and network meta-analysis. Headache. 2015;55(Suppl 4):221–235.
   Google Scholar
• Li BU, Murray RD, Heitlinger LA, et al. Is cyclic vomiting syndrome related to migraine? J Pediatr. 1999;134(5):567–572.
   Google Scholar
• Fuseau E, Petricoul O, Moore KH, et al. Clinical pharmacokinetics of intranasal sumatriptan. Clin Pharmacokinet. 2002;41(11):801–811.
   Google Scholar
• Hikita T, Kodama H, Kaneko S, et al. Sumatriptan as a treatment for cyclic vomiting syndrome: a clinical trial. Cephalalgia. 2011;31(4):504–507.
   Google Scholar
• Lin B, Zhou Z, Venkatesan T. Sumatriptan as abortive treatment in cyclic vomiting syndrome: a cross-sectional study. Cephalalgia Rep. 2020;3:2515816320958174.
   Google Scholar
• Blackwell C, Harding S. The clinical pharmacology of ondansetron. Eur J Cancer 1989;25:S21–4; discussion S25.
   Google Scholar
• Gralla RJ, Osoba D, Kris MG, et al. Recommendations for the use of antiemetics: evidence-based, clinical practice guidelines. J Clin oncol. 1999;17(9):2971–2994.
   Google Scholar
• • Smith R. Safety of ondansetron. Eur J Cancer 1989;25:S47–50; discussion S51
   Google Scholar
• BUK L. Treating cyclic vomiting syndrome in the emergency department: sooner appears better. J Pediatr. 2021;232:12–14.
   Google Scholar
• Pope D, Fernandes CM, Bouthillette F, et al. Frequent users of the emergency department: a program to improve care and reduce visits. Cmaj. 2000;162(7):1017–1020.
   Google Scholar
• Orr SL, Aube M, Becker WJ, et al. Canadian headache society systematic review and recommendations on the treatment of migraine pain in emergency settings. Cephalalgia. 2015;35(3):271–284.
   Google Scholar
• Kovacic K, Li BUK. Cyclic vomiting syndrome: a narrative review and guide to management. Headache. 2021;61(2):231–243.
   Google Scholar
• Gottfried-Blackmore A, Habtezion A, Nguyen L. Noninvasive vagal nerve stimulation for gastroenterology pain disorders. Pain Manag. 2021;11(1):89–96.
   Google Scholar
• Bonaz B, Sinniger V, Pellissier S. Vagus nerve stimulation at the interface of brain–gut interactions. Cold Spring Harb Perspect Med. 2019;9(8):a034199.
   Google Scholar
• Edvinsson L, Ho TW. CGRP receptor antagonism and migraine. Neurotherapeutics. 2010;7(2):164–175.
   Google Scholar
• Urits I, Jones MR, Gress K, et al. CGRP antagonists for the treatment of chronic migraines: a comprehensive review. Curr Pain Headache Rep. 2019;23(5):1–10.
   Google Scholar
• Ahern TL, Herring AA, Miller S, et al. Low-dose ketamine infusion for emergency department patients with severe pain. Pain Med. 2015;16(7):1402–1409.
   Google Scholar
• Hedegaard H, Bastian BA, Trinidad JP, et al. Regional differences in the drugs most frequently involved in drug overdose deaths: United States, 2017 National Vital Statistics Reports. 2019;68(12).
   Google Scholar
• Blonk MI, Koder BG, van den Bemt PM, et al. Use of oral ketamine in chronic pain management: a review. Eur J Pain. 2010;14(5):466–472.
   Google Scholar
• Carpenter A, Levinthal DJ, Binion DG, et al. Improvement of cyclic vomiting syndrome with outpatient ketamine infusions. Case Rep Gastroenterol. 2021;15(1):9–16.
   Google Scholar
• Cheung F, Doherty SM, Tatara AW. Ketamine in refractory cyclic vomiting syndrome: a case report and review of literature. J Pharm Pract. 2021;35:08971900211000684.
   Google Scholar
• Ahuja A, Kingsley MJ, Diable C, et al. Ketamine as a novel abortive therapy for cyclic vomiting syndrome attacks. Gastroenterology. 2018;154(6):558–559.
   Google Scholar
• Morgan CJ, Curran HV. Drugs ISCo. Ketamine use: a review. Addiction. 2012;107(1):27–38.
   Google Scholar